EVALUATION OF THE ENDOTHELIOPROTECTIVE EFFECT OF CERTAIN ANTIVIRAL AGENTS IN CONDITIONS OF EXPERIMENTAL ENDOTHELIAL DYSFUNCTION
Abstract and keywords
Abstract (English):
Given the high tropism of influenza and parainfluenza viruses to the vascular endothelium and the resulting high incidence of complications, the study of the endothelioprotective effect of antiviral agents is relevant. The aim of the study was to evaluate the endothelioprotective effect of certain antiviral agents in conditions of experimental endothelial dysfunction. Material and methods. Endothelial dysfunction was modeled on male C57BL/6 mice by injection of a solution of nitro-L-arginine methyl ester (intraperitoneally, 25 mg/kg, 7 days). Antiviral drugs rimantadine, oseltamivir, riamilovir, umifenovir, carboxymethylcellulose and gossypol copolymer were administered orally for 7 days after modeling endothelial dysfunction. Further, changes in the concentration of matrix metalloproteinases 2 and 9, endothelial and inducible nitric oxide synthases were evaluated in the supernatant of the abdominal aorta. Results. The study showed that the administration of a carboxymethylcellulose and gossypol copolymer, rimantadine and umifenovir to animals did not lead to significant changes in the concentration of metalloproteinases and isoenzymes of nitric oxide synthase. At the same time, against the background of the administration of oseltamivir and riamilovir, a significant de crease in the content of matrix metalloproteinases in the vessel supernatant was observed by (type 2 - 26.3% (p<0.05) and 20.4% (p<0.05); type 9 by 41.0% (p<0.05) and 19.5% (p<0.05), respectively) and inducible nitric oxide synthase (by 62.5% (p<0.05) and 57.2% (p<0.05)), while the concentration of the endothelial isoform, on the contrary, increased (by 64.5% (p<0.05) and 40.0% (p<0.05)). Conclusion. The study showed that the use of riamilovir and oseltamivir in animals with experimental endothelial dysfunction is accompanied by the development of endothelioprotective effects.

Keywords:
endothelial dysfunction, metalloproteinases, nitric oxide synthases, antiviral drugs
Text
Text (PDF): Read Download
References

1. Saloň A., De Boever P., Goswami N. Microvascular Changes during Viral Infections: A Systematic Review of Studies Using Retinal Vessel Diameter Assessments. Biomedicines. 2024;12(7):1488.

2. Khan A. O., Reyat J. S., Hill H., et al. Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature. Cardiovasc Res. 2022;118(15):3085-3096.

3. Butsabong T., Felippe M., Campagnolo P., Maringer K. The emerging role of perivascular cells (pericytes) in viral pathogenesis. J Gen Virol. 2021;102(8):001634. doihttps://doi.org/10.1099/jgv.0.001634.

4. MacLean M. A., Kamintsky L., Leck E. D., Friedman A. The potential role of microvascular pathology in the neurological manifestations of coronavirus infection. Fluids Barriers CNS. 2020;17(1):55.

5. Fosse J. H., Haraldsen G., Falk K., Edelmann R. Endothelial Cells in Emerging Viral Infections. Front Cardiovasc Med. 2021;8:619690. doi:10.3389/ fcvm.2021.619690

6. Grosicki M., Wojnar-Lason K., Mosiolek S., Mateuszuk L., Stojak M., Chlopicki S. Distinct profile of antiviral drugs effects in aortic and pulmonary endothelial cells revealed by highcontent microscopy and cell painting assays.

7. Amadi P. U., Agomuo E. N., Adumekwe C. W. Modulatory properties of cardiac and quercetin glycosides from Dacryodes edulis seeds during L-NAME-induced vascular perturbation. J Basic Clin Physiol Pharmacol. 2020

8. Lang T. A., Altman D. G. Basic statistical reporting for articles published in biomedical journals: the «Statistical Analyses and Methods in the Published Literature» or the SAMPL Guidelines. Int J Nurs Stud. 2015;52(1):5-9.

9. Chen Q., Jin M., Yang F., Zhu J., Xiao Q., Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013;2013:928315. doihttps://doi.org/10.1155/2013/928315

10. Egorov D., Kopaliani I., Ameln A. K, Speier S., Deussen A. Mechanism of pro-MMP9 activation in co-culture of pro-inflammatory macrophages and cardiomyocytes. Exp Cell Res. 2024;434(1

11. Ghosh A., Pechota A., Coleman D., Upchurch G. R Jr, Eliason J. L. Cigarette smoke induced MMP2 and MMP9 secretion from aortic vascular smooth cells is mediated via the Jak/Stat pathway. Hum Pathol. 2015;46(2):284

12. Roy R., Wilcox J., Webb A. J., O’Gallagher K. Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential. Int J Mol Sci. 2023;24(20): 15200

13. Carlström M., Weitzberg E., Lundberg J.O. Nitric Oxide Signaling and Regulation in the Cardiovascular System: Recent Advances. Pharmacol Rev. 2024;76(6):1038-1062. doi:10.1124/ pharmrev.124.001060

Login or Create
* Forgot password?